Fierce Pharma February 3, 2023
By Max Bayer, Fraiser Kansteiner

J&J’s pharmaceutical changes come as the company spins off its consumer healthcare group into a separate company called Kenvue. (BSR Agency/Getty Images News)

Three Johnson & Johnson pharmaceutical executives stood before a group of staff in the R&D unit Wednesday, joking about expensive Uber rides and one “phenomenal dinner” at a Japanese steakhouse while attending the J.P. Morgan Healthcare Conference in San Francisco in early January.

But just minutes earlier, the mood was anything but jovial, as the leaders explained to a nervous group of employees in the Janssen pharmaceutical unit an overhaul of operations for the infectious diseases and vaccine groups, with sweeping layoffs expected to claim staffers’ jobs in countries around the world. Some staff...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
The financial burden of drug shortages: 7 study takeaways
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
AI In Healthcare: A New Era Of Personalized Patient Care

Share This Article